Coverage
-
May 30, 2019
A convicted fraudster and his company have agreed to pay nearly $7 million combined to settle claims in New Jersey federal court that he tricked investors into giving him millions to develop an aspirin product and instead used most of the money for personal expenses, the U.S. Securities and Exchange Commission said Thursday.
1 other articles on this case.
View all »